3 By PBCP In newsPosted December 31, 2018Covis acquires rights to medicines from AstraZenecaAstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma), a Princeton BCP portfolio company, to sell READ MORE
3 By PBCP In newsPosted December 31, 2018Covis Obtains $350M External FinancingCapital One announced that it served as administrative agent and lead arranger for a $350 million senior credit facility for Covis Pharma B.V. (Covis), a Princeton BCP portfolio company. The [...] READ MORE